Xenetic Biosciences, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Xenetic Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2023.
  • Xenetic Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $100K, unchanged year-over-year.
  • Xenetic Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $300K, a 40% decline year-over-year.
  • Xenetic Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $300K, a 40% decline from 2022.
  • Xenetic Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $500K, a 25% increase from 2021.
  • Xenetic Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $400K, a 20% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $300K -$200K -40% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $500K +$100K +25% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $400K -$100K -20% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $500K -$354K -41.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 $854K -$578K -40.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $1.43M -$361K -20.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 $1.79M -$1.43M -44.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $3.22M +$631K +24.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-30
2015 $2.59M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.